Equities

Hunan Warrant Pharmaceutical Co Ltd

688799:SHH

Hunan Warrant Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)37.66
  • Today's Change-0.71 / -1.85%
  • Shares traded275.30k
  • 1 Year change-5.76%
  • Beta--
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments742688732
Total Receivables, Net227202143
Total Inventory363339301
Prepaid expenses168.128.75
Other current assets, total2.321122
Total current assets1,3501,2481,206
Property, plant & equipment, net621568475
Goodwill, net3232--
Intangibles, net778158
Long term investments534247
Note receivable - long term------
Other long term assets2020--
Total assets2,1772,0091,798
LIABILITIES
Accounts payable896181
Accrued expenses3010777
Notes payable/short-term debt7.06136.83
Current portion long-term debt/capital leases0.01----
Other current liabilities, total20911395
Total current liabilities336295260
Total long term debt1700
Total debt24136.83
Deferred income tax--2.330.01
Minority interest4562--
Other liabilities, total555358
Total liabilities453412318
SHAREHOLDERS EQUITY
Common stock949494
Additional paid-in capital850850850
Retained earnings (accumulated deficit)779652535
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,7241,5971,479
Total liabilities & shareholders' equity2,1772,0091,798
Total common shares outstanding949494
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.